Human medicines European public assessment report (EPAR): Buvidal, buprenorphine, Opioid-Related Disorders, Date of authorisation: 20/11/2018, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine / naloxone, Opioid-Related Disorders, Date of authorisation: 10/11/2017, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Moventig, naloxegol, Constipation,Opioid-Related Disorders, Date of authorisation: 07/12/2014, Revision: 10, Status: Authorised